Target intelligence / Profile preview

Invigorating spleen and lung

Molecular classification
Traditional Chinese Medicine therapeutic principle, Polyherbal therapy action
01

Overview

Invigorating spleen and lung (Jianpi Bufei) is a therapeutic principle in Traditional Chinese Medicine (TCM) and does not refer to a single molecular target, receptor, or enzyme. This concept describes a clinical strategy used to treat 'Spleen and Lung Qi Deficiency,' a TCM pattern frequently identified in patients with chronic respiratory diseases like COPD and asthma. Modern pharmacological studies indicate that herbal formulas following this principle exert their effects by modulating systemic inflammation, enhancing immune response, and improving skeletal muscle function via polypharmacology rather than a single-molecule mechanism. Consequently, it represents a category of multi-component herbal interventions rather than a specific biological target in the conventional drug discovery sense. (Sources: PMC6452583, PubMed: 30956637, NIH/NCCIH).

Other names
Jianpi BufeiStrengthening the spleen and tonifying the lungSpleen-invigorating and lung-supplyingJianpi Bufei principle
02

Mechanism of action

As a Traditional Chinese Medicine (TCM) therapeutic strategy, it functions through multi-target effects involving the down-regulation of pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-8) and the modulation of the TLR4/NF-κB and JAK/STAT signaling pathways to improve lung function and systemic immune status.

03

Biological functions

Immune system modulationAnti-inflammatory responseRespiratory function supportGastrointestinal regulation
04

Disease associations

Chronic obstructive pulmonary disease (COPD)Chronic bronchitisAsthmaAnorexiaChronic fatigue syndrome
05

Safety considerations

Drug-herb interactionsHeavy metal contamination in herbal sourcesLack of molecular standardizationVariable patient response due to TCM syndrome differentiation
06

Interacting drugs

Jianpi Bufei Granule

3 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor Necrosis Factor-alpha (TNF-α)Forced Expiratory Volume in 1 second (FEV1)Forced Vital Capacity (FVC)

Beyond the preview

Go deeper on Invigorating spleen and lung.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invigorating spleen and lung.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call